# CRD-733, a Novel PDE9 (Phosphodiesterase 9) Inhibitor, Reverses Pressure Overload–Induced Heart Failure

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/crd-733-a-novel-pde9-phosphodiesterase-9-inhibitor-reverses-pressure-overload/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniel A. Richards,Mark Aronovitz,Peiwen Liu,Gregory Martin,Kelly Tam,Suchita Pande,Richard H. Karas,Daniel M. Bloomfield,Michael E. Mendelsohn,Robert M. Blanton |
| Citations | 35 |
| DOI | 10.1161/circheartfailure.120.007300 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/8451972 |
| OpenAlex ID | https://openalex.org/W3123725515 |
| PMID | 33464954 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Peiwen Liu](https://scholariq.org/researchers/peiwen-liu/)

## Paper journal

- [Circulation Heart Failure](https://scholariq.org/journals/circulation-heart-failure/)

## Paper primary topic

- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)

## Paper topics

- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Nitric Oxide and Endothelin Effects](https://scholariq.org/topics/nitric-oxide-and-endothelin-effects/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.